Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease

Impaired Hepatic Ketogenesis in Moderately Obese Men With Hypertriglyceridemia

(2016) Gloria Lena Vega et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis

(2012) Shelley E. Keating et al.   JOURNAL OF HEPATOLOGY

Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction

(2011) Jeffrey D Browning et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey

(2011) Pia Pajunen et al.   BMC PUBLIC HEALTH

Hepatic fatty acid partitioning

(2011) Leanne Hodson et al.   CURRENT OPINION IN LIPIDOLOGY

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

(2011) K. Hallsworth et al.   GUT

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

(2011) Romina Lomonaco et al.   HEPATOLOGY

Fat burners: nutrition supplements that increase fat metabolism

(2011) A. E. Jeukendrup et al.   Obesity Reviews

Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease

(2011) Ann K Daly et al.   Expert Review of Gastroenterology & Hepatology

Insulin resistance, adipose depots and gut: Interactions and pathological implications

(2010) Amalia Gastaldelli et al.   DIGESTIVE AND LIVER DISEASE

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

(2010) Luca Valenti et al.   HEPATOLOGY

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

(2010) Elizabeth M. Brunt et al.   HEPATOLOGY

Maximal lipid oxidation in patients with type 2 diabetes is normal and shows an adequate increase in response to aerobic training

(2009) M. Mogensen et al.   DIABETES OBESITY & METABOLISM

Are substrate use during exercise and mitochondrial respiratory capacity decreased in arm and leg muscle in type 2 diabetes?

(2009) S. Larsen et al.   DIABETOLOGIA

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women

(2009) Satoru Kodama   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Liver fat and lipid oxidation in humans

(2009) Anna Kotronen et al.   LIVER INTERNATIONAL

Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat

(2008) Jean-Pierre Després et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

(2008) G. Targher et al.   DIABETOLOGIA

Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects

(2008) Kevin M. Korenblat et al.   GASTROENTEROLOGY

Hepatic Overexpression of Hormone-sensitive Lipase and Adipose Triglyceride Lipase Promotes Fatty Acid Oxidation, Stimulates Direct Release of Free Fatty Acids, and Ameliorates Steatosis

(2008) Brendan N. Reid et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease

(2007) Elisa Fabbrini et al.   GASTROENTEROLOGY